TipRanks
Alaunos Therapeutics (DE:WEK0)
FRANKFURT:WEK0
Germany Market
WEK0
Alaunos Therapeutics
RESEARCH TOOLSreports

Alaunos Therapeutics (WEK0) Income Statement

0 Followers

Alaunos Therapeutics Income Statement

Last quarter (Q2 2026), Alaunos Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Alaunos Therapeutics's net income was $-952.00K. See Alaunos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 5.00K$ 10.00K$ 5.00K$ 2.92M$ 398.00K
Gross Profit
$ -1.36M$ -352.00K$ -4.80M$ -19.60M$ -46.88M
Operating Expenses
$ 2.87M$ 4.46M$ 29.47M$ 15.51M$ 30.67M
Depreciation and Amortization
$ 7.00K$ 2.00K$ 2.31M$ 2.76M$ 2.60M
EBITDA
$ -4.17M$ -4.68M$ -30.90M$ -31.82M$ -74.97M
Operating Income
$ -4.22M$ -4.81M$ -34.27M$ -35.10M$ -77.55M
Other Income/Expenses
$ 49.00K$ 133.00K$ -873.00K$ -2.63M$ -1.20M
Pretax Income
$ -4.18M$ -4.68M$ -35.14M$ -37.73M$ -78.75M
Net Income
$ -4.18M$ -4.68M$ -35.14M$ -37.73M$ -78.75M
Per Share Metrics
Basic EPS
$ -2.20$ -2.92$ -21.97$ -25.97$ -53.80
Diluted EPS
$ -2.20$ -2.92$ -21.97$ -25.97$ -53.80
Weighted Average Shares Outstanding
 1.95M 1.60M 1.60M 1.45M 1.43M
Weighted Average Shares Outstanding (Diluted)
 1.95M 1.60M 1.60M 1.45M 1.43M
Currency in USD

Alaunos Therapeutics Earnings and Revenue History